Questions And Answer | Back Directory | [Description]
Ibalizumab (also known as ibalizumab-uiyk and formerly known as TNX-355) is a monoclonal antibody that binds to CD4 receptors on the surface of CD4-positive cells, preventing HIV particle entry into the lymphocytes. |
Hazard Information | Back Directory | [Uses]
Ibalizumab is an advanced and current antibody in development for the treatment of HIV/AIDS. It has been developed by Taimed biologics and Theratechnologies. |
|
Company Name: |
AntibodySystem
|
Tel: |
17762345272 18162686757 |
Website: |
www.antibodysystem.com |
|